Ishikawa Prefectural Central Hospital

Ishikawa 920-8530

1 studies enrolling now · 5 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Chronic Obstructive Pulmonary Disease (COPD), Dyslipidemias, Familial Hypercholesterolemia, High Cholesterol, Hypercholesterolemia, Moderately to Severely Active Crohns Disease, Paroxysmal Nocturnal Hemoglobinuria

Studies at this site

• A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease — Recruiting now
• A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors — Running, not enrolling
• A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Running, not enrolling
• Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling